Options: Show MedDRA Preferred Terms
Side effect | Data for drug | Placebo | Labels | ||
---|---|---|---|---|---|
1 | 2 | 3 | |||
Abscess | x | ||||
Infection | x | x | |||
Diarrhoea | x | ||||
Rash | x | ||||
Extravasation | x | x | |||
Body temperature increased | x | x | |||
Flatulence | x | ||||
Gastrointestinal haemorrhage | x | ||||
Hyperkalaemia | x | ||||
Hyponatraemia | x | ||||
Nausea | x | ||||
Necrosis | x | ||||
Phlebitis | x | x | |||
Ulcer | x | ||||
Venous thrombosis | x | x | |||
Vomiting | x | ||||
Abdominal discomfort | x | ||||
Tenderness | x | ||||
Fluid overload | x | ||||
Gastrointestinal ulcer haemorrhage | x |
Information about indications was extracted from the indications and usage sections of the labels.
standard – alternative
100% | ||
75% | ||
50% | ||
10% | ||
frequent (1% to 100%) | ||
infrequent (0.1% to 1%) | ||
rare (<0.1%) | ||
postmarketing | ||
0% | ||
no frequency information | ||
not found on label |